{"id":388028,"date":"2020-11-24T16:06:01","date_gmt":"2020-11-24T21:06:01","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=388028"},"modified":"2020-11-24T16:06:01","modified_gmt":"2020-11-24T21:06:01","slug":"adamas-to-present-at-upcoming-evercore-isi-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/","title":{"rendered":"Adamas to Present at Upcoming Evercore ISI Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">EMERYVILLE, Calif., Nov.  24, 2020  (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company\u2019s Chief Executive Officer, is scheduled to present at the Evercore ISI 3<sup>rd<\/sup> Annual HealthCONx Conference on Tuesday, December 1<sup>st<\/sup> at 11:45 am Eastern Time (8:45 am Pacific).<\/p>\n<p align=\"justify\">The presentation will be webcast from the investor relations section of the Adamas website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GRm_vfcvuQdNVLY9DrJ9eVM-fqx6_jypQCbJMi_6FjfebvQK0loj25lF5bd-Wyp5IqeOzqZnARrnqCPNd3iPcBbo6lL59iF_IXZZo4iC3Libvkkbo6D9I3jt6MBIW0mmEEY1780O-eGNMQNX71xho9dm9xMoEom6mcNVdJKfO8w=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/ir.adamaspharma.com\/events-presentations<\/a>. Archived versions of the webcast will be available via replay for 30 days following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About Adamas Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>At Adamas our vision is clear \u2013 to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=siY8G2zxZD4nf30ZxPenvOM2ZNRawJb_rALsLUzHhp7hoUZJyMcXbf6S35kH0VvXcD_Jehk5sBPLaZh_hQu-QtZqK_0NEKtl5GnQ2Vsnx8c=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.adamaspharma.com<\/a>.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong><br \/>\n        <br \/>Sarah Mathieson<br \/>Vice President, Corporate Communications<br \/>510-450-3528<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yVu6Ls03kCTzCA1TFDjYuUkl_LcvFajMkwiai6PsTL5ABVfTZqJ7UBduyTTtspVsDf_FzM0d-R_HJRF5xaqv797WTGzNuY-h0Xho302Aj5dqTL1i2yOoUUQn7vAf8Cum\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">smathieson@adamaspharma.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Peter Vozzo<br \/>Managing Director, Westwicke<br \/>443-213-0505<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_5ncR1foxcppHOZsOwGxmw3lm-NYJWJXKdLbxDzjE2L_SGR__y7eyy2b7g4FNoJeqK6dt0ECgJ-YHkL7smRZApaPofBQX_r4DyVXiFyIv6s=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">peter.vozzo@westwicke.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/905e5fdd-a83f-4604-b2b6-bbe8bff372fe\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company\u2019s Chief Executive Officer, is scheduled to present at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1st at 11:45 am Eastern Time (8:45 am Pacific). The presentation will be webcast from the investor relations section of the Adamas website at http:\/\/ir.adamaspharma.com\/events-presentations. Archived versions of the webcast will be available via replay for 30 days following the presentation. About Adamas Pharmaceuticals, Inc. At Adamas our vision is clear \u2013 to deliver innovative medicines that reduce the burden of neurological &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adamas to Present at Upcoming Evercore ISI Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-388028","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company\u2019s Chief Executive Officer, is scheduled to present at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1st at 11:45 am Eastern Time (8:45 am Pacific). The presentation will be webcast from the investor relations section of the Adamas website at http:\/\/ir.adamaspharma.com\/events-presentations. Archived versions of the webcast will be available via replay for 30 days following the presentation. About Adamas Pharmaceuticals, Inc. At Adamas our vision is clear \u2013 to deliver innovative medicines that reduce the burden of neurological &hellip; Continue reading &quot;Adamas to Present at Upcoming Evercore ISI Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T21:06:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adamas to Present at Upcoming Evercore ISI Conference\",\"datePublished\":\"2020-11-24T21:06:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/\"},\"wordCount\":184,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/\",\"name\":\"Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\",\"datePublished\":\"2020-11-24T21:06:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-to-present-at-upcoming-evercore-isi-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adamas to Present at Upcoming Evercore ISI Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/","og_locale":"en_US","og_type":"article","og_title":"Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk","og_description":"EMERYVILLE, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company\u2019s Chief Executive Officer, is scheduled to present at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1st at 11:45 am Eastern Time (8:45 am Pacific). The presentation will be webcast from the investor relations section of the Adamas website at http:\/\/ir.adamaspharma.com\/events-presentations. Archived versions of the webcast will be available via replay for 30 days following the presentation. About Adamas Pharmaceuticals, Inc. At Adamas our vision is clear \u2013 to deliver innovative medicines that reduce the burden of neurological &hellip; Continue reading \"Adamas to Present at Upcoming Evercore ISI Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T21:06:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adamas to Present at Upcoming Evercore ISI Conference","datePublished":"2020-11-24T21:06:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/"},"wordCount":184,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/","name":"Adamas to Present at Upcoming Evercore ISI Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=","datePublished":"2020-11-24T21:06:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTg0NSMzODQyNjYwIzIwMDY5NjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-to-present-at-upcoming-evercore-isi-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adamas to Present at Upcoming Evercore ISI Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=388028"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388028\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=388028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=388028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=388028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}